1. Home
  2. EQIX vs BMY Comparison

EQIX vs BMY Comparison

Compare EQIX & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equinix Inc. REIT

EQIX

Equinix Inc. REIT

N/A

Current Price

$971.99

Market Cap

103.1B

Sector

Real Estate

ML Signal

N/A

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

N/A

Current Price

$59.02

Market Cap

127.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EQIX
BMY
Founded
1998
1887
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.1B
127.0B
IPO Year
2000
2006

Fundamental Metrics

Financial Performance
Metric
EQIX
BMY
Price
$971.99
$59.02
Analyst Decision
Strong Buy
Hold
Analyst Count
35
28
Target Price
★ $1,234.88
$65.25
AVG Volume (30 Days)
610.3K
★ 9.0M
Earning Date
10-28-2026
10-29-2026
Dividend Yield
2.03%
★ 4.32%
EPS Growth
61.88
★ 178.46
EPS
★ 13.96
3.98
Revenue
$5,998,545,000.00
★ $48,194,000,000.00
Revenue This Year
$11.77
$4.23
Revenue Next Year
$11.35
N/A
P/E Ratio
$72.93
★ $14.66
Revenue Growth
★ 7.85
N/A
52 Week Low
$720.62
$47.58
52 Week High
$1,128.68
$68.64

Technical Indicators

Market Signals
Indicator
EQIX
BMY
Relative Strength Index (RSI) 39.63 39.40
Support Level $930.35 $55.66
Resistance Level $984.17 $60.93
Average True Range (ATR) 33.74 1.71
MACD -4.65 -0.46
Stochastic Oscillator 3.38 13.93

Price Performance

Historical Comparison
EQIX
BMY

About EQIX Equinix Inc. REIT

Equinix is one of the leading providers of cloud- and carrier-neutral data centers, offering colocation and interconnection services to hyperscalers and businesses. Equinix operates 270 properties in 77 metropolitan areas across 36 countries, serving over 10,000 customers. About 70% of Equinix's revenue comes from renting physical space, which allows hyperscalers and other clients to store servers, data storage, and networking equipment. The other 30% of revenue is generated primarily through interconnection services (20%) and other managed services (10%).

About BMY Bristol-Myers Squibb Company

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: